1. Introduction {#sec1-molecules-24-00304}
===============

Qing Shan Lu Shui which is a kind of Kuding tea, is made by processing the leaves of *Ligustrum robustum* (Roxb.) Blume. The genus *Ligustrum* in the family Oleaceae contains phenolic constituents such as quinic acid derivatives, flavonoids, and monoterpene glycosides, and shows in vitro antioxidative activity \[[@B1-molecules-24-00304]\]. Qing Shan Lu Shui tea is consumed in some parts of China, for health-benefits; it shows various pharmacological effects, such as anti-inflammatory, antioxidative, and antiproliferative activities \[[@B2-molecules-24-00304],[@B3-molecules-24-00304],[@B4-molecules-24-00304],[@B5-molecules-24-00304],[@B6-molecules-24-00304]\]. A previous report has demonstrated that aqueous extracts of the processed leaves of *Ligustrum robustum*, dose-dependently scavenged superoxide radicals, inhibited lipid peroxidation, and prevented hemolysis of the red blood cells \[[@B2-molecules-24-00304]\]. We have previously reported that two novel monoterpene glycosides, liguroside A and liguroside B, inhibited the catalytic activity of leukocyte-type 12-lipoxygenase ([Figure 1](#molecules-24-00304-f001){ref-type="fig"}) \[[@B7-molecules-24-00304]\]. Leukocyte-type 12-lipoxygenase not only oxygenates the free fatty acids (such as arachidonic acid) to produce 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid (12-HPETE), but also fatty acids that have esterified to cholesterol in the low-density lipoprotein (LDL) particle, which contributes to the formation of oxidized LDL and the development of atherosclerosis \[[@B8-molecules-24-00304],[@B9-molecules-24-00304]\]. Our previous report demonstrated that guava leaf extracts inhibited the leukocyte-type 12-lipoxygenase activity, as well as cell-mediated LDL oxidation, and attenuated the development of atherosclerosis in apoE-knockout mice \[[@B10-molecules-24-00304]\]. To further elucidate the beneficial components contained in the Qing Shan Lu Shui, we isolated novel monoterpene glycosides showing inhibitory effects on the leukocyte-type 12-lipoxygenase activity from the Qing Shan Lu Shui. We have also reported that the inhibitors from the Qing Shan Lu Shui irreversibly inhibit the catalytic activity of leukocyte-type 12-lipoxygenase.

2. Results and Discussion {#sec2-molecules-24-00304}
=========================

In the present study, we isolated two new monoterpene glycosides, liguroside C and liguroside D, which inhibited the leukocyte-type 12-lipoxygenase from the Qing Shan Lu Shui tea.

Liguroside C, an off-white amorphous powder, exhibited an HRESIMS peak at *m*/*z* 639.2650 \[M − H\]^−^ (calcd. for C~31~H~43~O~14~, 639.2658). The ^1^H-NMR spectrum of liguroside A displayed signals due to a *trans p*-coumaroyl group \[δ 7.51 (2H, d, *J* = 8.4 Hz), δ 6.85 (2H, d, *J* = 8.4 Hz), δ 7.64 (1H, d, *J* = 15.6 Hz), and 6.33 (1H, d, *J* = 15.6 Hz)\], in the aromatic proton region. The existence of β-glucosyl and α-rhamnosyl moieties was deduced by two anomeric proton signals at δ 4.78 (d, *J* = 7.8 Hz) and δ 5.17 (brs), respectively. Proton signals due to an exomethylene (δ 5.19 and 5.18), three vinyls (δ 5.92, 5.63 and 5.59), a methylene (δ 2.32), and three tertiary methyl (δ 1.31, 1.22, 1.22) groups were observed in the aliphatic proton region ([Table 1](#molecules-24-00304-t001){ref-type="table"} and [Figure S1](#app1-molecules-24-00304){ref-type="app"}). The ^13^C-NMR resonances of liguroside C were similar to those of liguroside A \[[@B7-molecules-24-00304]\], except for 10 signals of a monoterpene moiety ([Table 1](#molecules-24-00304-t001){ref-type="table"} and [Figures S2--S5](#app1-molecules-24-00304){ref-type="app"}). The monoterpene moiety was assigned as a (5*E*)-3,7-dimethyl-1,5-octadiene-3,7-diol analogue, based on the correlations from the HMBC experiment of liguroside C, as shown in [Figure 2](#molecules-24-00304-f002){ref-type="fig"}. Among the signals of monoterpene unit, the signals of the two methyls (δ 24.8, C-8, 9) and those attached to the oxygenated tertiary carbon (δ 81.6, C-7) were close to those due to the methyls (δ 24.1) and the methine (δ 80.6) carbons of liguroside A \[[@B7-molecules-24-00304]\], suggesting that a hydroperoxy group was allocated to the C-7 position of liguroside C; this suggestion was supported by its high-resolution electrospray ionization mass spectroscopy (HRESIMS) analysis. On the basis of these data, the structure of liguroside C was concluded to be (5*E*)-7-hydroperoxy-3,7-dimethyl-1,5-octadienyl-3-*O*-(α-[l]{.smallcaps}-rhamnopyranosyl)-(1′′→3′)-(4′′′-*O*-*trans*-*p*-coumaroyl)-β-[d]{.smallcaps}-glucopyranoside ([Figure 2](#molecules-24-00304-f002){ref-type="fig"}).

Liguroside D was obtained as an off-white amorphous powder, which has the molecular formula C~31~H~44~O~14~, based on a pseudomolecular ion peak at *m*/*z* 639.2644 \[M − H\]^−^ (calcd. for C~31~H~43~O~14~, 639.2658) in the HRESIMS. The ^1^H- and ^13^C-NMR data corresponding to the acyl and glycosyl moieties of liguroside D were close to those of liguroside C, suggesting that an α-[l]{.smallcaps}-rhamnopyranosyl)-(1′′→3′)-(4′′′-*O*-*trans*-*p*-coumaroyl)-β-[d]{.smallcaps}-glucopyranosyl unit is present in liguroside D. The ^1^H- and ^13^C-NMR data of liguroside D, except for the signals due to the acyl and glycosyl units, showed the signals of an exomethylene (δ~H~ 4.89, 4.90; δ~C~ 113.7), a vinyl (δ~H~ 5.35; δ~C~ 121.4), oxygenated methine (δ~H~ 4.21; δ~C~ 88.8) and methylene (δ~H~ 4.32, 4.22; δ~C~ 65.8), mutually coupled methylenes (δ~H~ 2.03, 1.64, 1.56; δ~C~ 36.0, 29.5), two vinyl methyls (δ~H~ 1.67, 1.65; δ~C~ 17.0, 16.3), and two *sp*^2^ carbons (δ~C~ 145.4, 140.8) ([Table 1](#molecules-24-00304-t001){ref-type="table"} and [Figures S6--S9](#app1-molecules-24-00304){ref-type="app"}). The NMR data of the monoterpene unit ([Table 1](#molecules-24-00304-t001){ref-type="table"}) and the HMBC experiment of liguroside D ([Figure 2](#molecules-24-00304-f002){ref-type="fig"} and [Figure S10](#app1-molecules-24-00304){ref-type="app"}) suggested that the (2*E*)-6-hydroxy-3,7-dimethyl-2,7-octadien-1-ol analogue was involved in liguroside D, as a monoterpene unit. The significant downfield shift of the oxygenated methine resonance (δ~C~ 88.8) and HRESIMS data of liguroside D showed that the hydroxy group of C-6 position in liguroside D is replaced by the hydroperoxy group \[[@B11-molecules-24-00304]\]. The NMR feature including the HMBC correlations of liguroside D confirmed that the structure of liguroside D was assigned to (2*E*)-6-hydroxy-3,7-dimethyl-2,7-octadienyl-3-*O*-(α-[l]{.smallcaps}-rhamnopyranosyl)-(1′′→3′)-(4′′′-*O*-*trans*-*p*-coumaroyl)-β-[d]{.smallcaps}-glucopyranoside ([Figure 2](#molecules-24-00304-f002){ref-type="fig"}).

As shown in [Figure 3](#molecules-24-00304-f003){ref-type="fig"}, liguroside C and liguroside D, dose-dependently inhibited the leukocyte-type 12-lipoxygenase activity with IC~50~ values of 2.9 μM and 4.2 μM, respectively. The inhibitory potencies of liguroside C and liguroside D were comparable to those of liguroside A and liguroside B (IC~50~ values of 1.7 μM and 0.7 μM) \[[@B7-molecules-24-00304]\]. In our previous study, the leukocyte-type 12-lipoxygenase inhibitory assay-guided fractionation of the 30% aqueous ethanol soluble portion of the ethyl acetate extract was carried out using a reversed-phase HPLC \[[@B7-molecules-24-00304]\]. We analyzed the obtained active fraction containing ligurosides A, B, C, and D using a reversed-phase HPLC ([Figure S11A](#app1-molecules-24-00304){ref-type="app"}). Ligurosides C and D were separated by another HPLC condition ([Figure S11B](#app1-molecules-24-00304){ref-type="app"}). Our previous report indicated that the contents of ligurosides A and B in the Qing Shan Lu Shui leaves were 0.85% and 0.31% (*w*/*w*), respectively \[[@B7-molecules-24-00304]\]. The contents of ligurosides C and D were 0.23% and 0.50% (*w*/*w*), respectively.

Leukocyte-type 12-lipoxygenase shows an irreversible suicidal inactivation in which the reaction ceases within a few minutes resulting in a by-product of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid \[[@B12-molecules-24-00304],[@B13-molecules-24-00304]\]. As all four compounds which inhibited leukocyte-type 12-lipoxygenase had a hydroperoxy group in the monoterpene moiety, we tested the reversibility of the leukocyte-type 12-lipoxygenase inhibition by ligurosides. The leukocyte-type 12-lipoxygenase was preincubated for 5 min with 6 μM of each liguroside or quercetin (used as a control of reversible inhibition of the enzyme), either of which almost completely inhibited the enzyme activity. The preincubation mixture was 200-fold diluted 0, 5, 15, and 30 min, before starting the enzyme reaction under the standard condition for the lipoxygenase assay. As shown in [Figure 4](#molecules-24-00304-f004){ref-type="fig"}, the leukocyte-type 12-lipoxygenase activity was quickly recovered after dilution of quercetin and the inhibition was hardly observed after 15 min. On the other hands, tested ligurosides inhibited the leukocyte-type 12-lipoxygenase activity, even after 30 min, indicating an irreversible inhibition of the enzyme activity ([Figure 4](#molecules-24-00304-f004){ref-type="fig"}).

*p*-Coumaric acid, as a part of the ligurosides, showed no inhibition on the leukocyte-type 12-lipoxygenase activity, suggesting that the inhibitory effects of liguroside A and liguroside B can be attributed to the monoterpene unit with the hydroperoxy group \[[@B7-molecules-24-00304]\]. On the other hand, monoterpene glycosides have the same backbone structure but did not have a hydroperoxy group (such as kudingoside A and lipedoside B-III) contained in the tea ([Figure 1](#molecules-24-00304-f001){ref-type="fig"}), and did not inhibit the enzyme activity ([Figure 5](#molecules-24-00304-f005){ref-type="fig"}). We reduced a hydroperoxy group in liguroside A using triphenylphosphine. The structure of the reduced compound was confirmed by mass spectrometry as kudingoside B, as described previously ([Figure 1](#molecules-24-00304-f001){ref-type="fig"}) \[[@B7-molecules-24-00304]\]. The resultant compound, kudingoside B, showed a lower inhibitory effect on the enzyme ([Figure 5](#molecules-24-00304-f005){ref-type="fig"}), strongly suggesting that the hydroperoxy group of ligurosides played a key role in the irreversible inhibition of the leukocyte-type 12-lipoxygenase by the compounds. The detailed mechanism of the enzyme inhibition by the hydroperoxy group of ligurosides remains to be elucidated. In the suicidal inactivation of the enzyme, 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid was further converted to 14,15-leukotriene A~4~, an epoxide product, by the leukocyte-type 12-lipoxygenase, itself, and was incorporated into the enzyme protein, by a covalent binding \[[@B12-molecules-24-00304]\]. In contrast, 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid, a major product of the leukocyte-type 12-lipoxyganase, did not inactivate the enzyme as fast as the 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, and slowly incorporated into the enzyme that did not bind covalently \[[@B12-molecules-24-00304]\]. It is well-known that terpenes, such as linalool and geraniol can autoxidize and form oxidation products such as hydroperoxides, when exposed to air \[[@B14-molecules-24-00304]\]. It was also reported that the hydroxy-group-esterified linalyl acetate oxidizes on air-exposure, forming hydroperoxides, which then turns into epoxide \[[@B15-molecules-24-00304]\]. Therefore, the liguroside epoxides derived from the hydroperoxy group of the ligurosides might contribute to the irreversible inhibition of the leukocyte-type 12-lipoxygenase.

We investigated whether the ligurosides affect the catalytic activities of the arachidonic acid, metabolizing enzymes other than the leukocyte-type 12-lipoxygenase. As shown in [Figure 6](#molecules-24-00304-f006){ref-type="fig"}, liguroside A also inhibited 15-lipoxygenase, cyclooxygenase-1, and cyclooxygenase-2, with IC~50~ values of 3.2, 21.5, and 16.9 μM, respectively. In contrast, platelet-type 12-lipoxygenase was almost unaffected by liguroside A up to 100 μM. Kishimoto et al. reported that the platelet-type 12-lipoxygenase did not show a rapid inactivation by the 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, presumably because the enzyme hardly converted the 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid to an epoxide product \[[@B12-molecules-24-00304]\]. It is known that suicidal inactivation is hardly observed in the platelet-type 12-lipoxygenase that did not produce the 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid as a by-product \[[@B12-molecules-24-00304]\]. Further investigation is necessary to elucidate the mechanism of inhibition of the leukocyte-type 12-lipoxygenase by the ligurosides.

3. Materials and Methods {#sec3-molecules-24-00304}
========================

3.1. Materials {#sec3dot1-molecules-24-00304}
--------------

Arachidonic acid was obtained from the Nu-Chek prep (Elysian, MN, USA). Authentic 15-hydroxy-11,13-eicosadienoic acid (15-HEDE) was prepared by the incubation of soybean lipoxygenase type I (Sigma-Aldrich, St. Louis, MO, USA), with 11,14-eicosadienoic acid (Cayman Chemical, Ann Arbor, MI, USA), followed by purification with HPLC \[[@B9-molecules-24-00304]\]. Kudingoside B was prepared by the incubation of liguroside A, with triphenylphosphine, as previously described \[[@B7-molecules-24-00304]\]. All other reagents and chemicals were commercially available as extra-pure-grade products.

3.2. Isolation of the Monoterpene Glycosides {#sec3dot2-molecules-24-00304}
--------------------------------------------

The aqueous ethanol extract of the Qing Shan Lu Shui was prepared, as described previously \[[@B7-molecules-24-00304]\]. Briefly, the dried leaves of the Qing Shan Lu Shui were extracted with 50% aqueous ethanol. After filtration and evaporation of the extract, the residue was partitioned between water and ethyl acetate. The organic layer was evaporated, and then, the resulting residue was re-dissolved with 45% aqueous methanol or 53% aqueous methanol. The 45% aqueous methanol extract was separated by a preparative HPLC, to afford liguroside C (retention time 31.5 min) and liguroside D (retention time was 37.6 min). HPLC was performed on a Waters Alliance 2695 separations module. Reverse-phase HPLC in an isocratic condition was conducted on a COSMOSIL Cholester column (5-μm particle, 250 × 4.6 mm i.d., Nacalai, Kyoto, Japan), developed with methanol--water--acetic acid (45:55:0.01, *v*/*v*), at 40 °C and a flow rate of 1.0 mL/min. Detection was affected at 200--700 nm. The 53% aqueous methanol extract was separated by a preparative HPLC to afford the kudingoside A (retention time 31.5 min) and lipedoside B-III (retention time 37.6 min). HPLC was performed under the same conditions as those described above, but was not developed with methanol-ater-acetic acid (53:47:0.01, *v*/*v*).

3.3. Structural Analysis {#sec3dot3-molecules-24-00304}
------------------------

^1^H- and ^13^C-NMR spectra were measured in acetone-*d*~6~ on a Varian NMR System 600 MHz (600 MHz for ^1^H-NMR and 151 MHz for ^13^C-NMR) instrument; chemical shifts were given in δ (ppm) values, relative to that of the solvent (δ~H~: 2.04; δ~C~: 29.8), on a tetramethylsilane scale. The standard pulse sequences programmed for the instrument were used for each 2D-NMR experiment (^1^H-^1^H COSY, HSQC, and HMBC). The *J*~CH~ value was set at 8 Hz in the HMBC experiment. Mass spectra were obtained on a Bruker MicrOTOF II spectrometer (Bruker, Billerica, MA, USA), using ESI source in a negative-ion mode.

3.4. Enzyme Assay {#sec3dot4-molecules-24-00304}
-----------------

The lipoxygenase and cyclooxygenase reactions were carried out, as described previously \[[@B9-molecules-24-00304],[@B10-molecules-24-00304],[@B16-molecules-24-00304]\]. Briefly, leukocyte-type 12-lipoxygenase or 15-lipoxygenase-1 was preincubated with inhibitors, in a volume of 0.2 mL in 100 mM Tris-HCl buffer, at pH 7.4, for 5 min at 30 °C, and was then incubated with 25 μM arachidonic acid for 5 min at 30 °C. Platelet-type 12-lipoxygenase reaction was carried out the as same as leukocyte-type 12-lipoxygenase reaction, except for incubation condition of 30 min at 37 °C. 5-Lipoxygenase was preincubated in 100 mM Tris-HCl buffer at pH 7.4, 2 mM CaCl~2~, and 2 mM ATP, with inhibitors, for 5 min on ice and then incubated with 25 μM arachidonic acid, for 5 min at 30 °C. To reduce the metabolites of each lipoxygenase isozyme, we added glutathione peroxidase (0.1 unit) and 5 mM glutathione to the mixture, followed by incubation for another 20 min. The enzyme reactions of cyclooxygenase-1 and cyclooxygenase-2 were carried out, as described previously \[[@B10-molecules-24-00304],[@B17-molecules-24-00304]\]. Briefly, cyclooxygenase-1 and cyclooxygenase-2 were preincubated with inhibitors in a volume of 0.2 mL in 100 mM Tris-HCl buffer at pH 7.4, 2 μM hematin, and 5 mM tryptophan, for 5 min at 24 °C, and then incubated with 25 μM linoleic acid, for 5 min at 24 °C. After the reaction was quenched by an addition of 50 mM HCl, 0.5 nmol of 15-HEDE were added as an internal standard for enzyme reactions. The products extracted with ice-cold diethyl ether were analyzed by a reverse-phase HPLC, using a Waters Alliance system equipped with a COSMOSIL 5C18-MS-II column (5-μm particle, 250 × 4.6 mm i.d., Nacalai), with a solvent system of methanol-water-acetic acid (80:20:0.01, *v*/*v*), at a flow rate of 1 mL/min, as previously described \[[@B17-molecules-24-00304]\]. Absorption at 235 nm was continuously monitored, using a Waters 2489 UV/Visible detector (Waters, Milford, MA, USA). Protein concentration was determined using a bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA), with bovine serum albumin as a standard.
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The following are available online, Figure S1: ^1^H-NMR spectrum of liguroside C in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S2: ^13^C-NMR spectrum of liguroside C in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (151 MHz); Figure S3: ^1^H-^1^H COSY NMR spectrum of liguroside C in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S4: HSQC NMR spectrum of liguroside C in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S5: HMBC NMR spectrum of liguroside C in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S6: ^1^H-NMR spectrum of liguroside D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S7: ^13^C-NMR spectrum of liguroside D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (151 MHz); Figure S8: ^1^H-^1^H COSY NMR spectrum of liguroside D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S9: HSQC NMR spectrum of liguroside D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S10: HMBC NMR spectrum of liguroside D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (600 MHz); Figure S11: HPLC profiles of ligurosides A, B, C, and D.

###### 

Click here for additional data file.
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![Structures of the known monoterpene glycosides; (**1**) liguroside A, (**2**) liguroside B, (**5**) lipedoside B-III, (**6**) kudingoside B, and (**7**) kudingoside A.](molecules-24-00304-g001){#molecules-24-00304-f001}

![Structures of the new monoterpene glycosides, ligurosides C (**3**) and D (**4**).](molecules-24-00304-g002){#molecules-24-00304-f002}

![Inhibition of the leukocyte-type 12-lipoxygenase activity by liguroside C (closed circles) and liguroside D (open circles). Leukocyte-type 12-lipoxygenase was incubated with 25 μM arachidonic acid at 30 °C for 5 min in the standard reaction mixture, in the presence of inhibitors at various concentrations and the products were quantified using a reverse-phase HPLC. Relative enzyme activities, as compared with the activity without inhibitors, are shown.](molecules-24-00304-g003){#molecules-24-00304-f003}

![Reversibility analysis of the leukocyte-type 12-lipoxygenase inhibition. The leukocyte-type 12-lipoxygenase was preincubated with 6 μM quercetin, liguroside A, liguroside C, and liguroside D, at 30 °C, for 5 min, and then the mixture was 200-fold diluted in the standard lipoxygenase reaction mixture. After 0, 5, 15, and 30 min, the mixtures were incubated with 25 μM arachidonic acid at 30 °C, for 5 min. The reaction without dilution of inhibitors (no dilution) was also carried out. The relative enzyme activities, as compared with the activity without inhibitors, are shown.](molecules-24-00304-g004){#molecules-24-00304-f004}

![Inhibition of the leukocyte-type 12-lipoxygenase activity by liguroside A (closed circles), kudingoside B (grey circles), kudingoside A (open circles), and lipedoside B-III (open lozenges). Leukocyte-type 12-lipoxygenase was incubated with 25 μM arachidonic acid, at 30 °C, for 5 min, in the standard reaction mixture in the presence of inhibitors, at various concentrations, and the products were quantified using a reverse-phase HPLC. Relative enzyme activities, as compared with the activity without inhibitors, are shown.](molecules-24-00304-g005){#molecules-24-00304-f005}

![Inhibition of various lipoxygenase and cyclooxygenase activities by liguroside A. Reactions were carried out under the standard conditions in the presence of liguroside A at various concentrations and the products were quantified, using a reverse-phase HPLC. Relative enzyme activities of the 15-lipoxygenase-1 (closed circles), platelet-type 12-lipoxygenase (open circles), 5-lipoxygenase (open lozenges), cyclooxygenase-1 (open triangles), and cyclooxygenase-2 (closed triangles), as compared to the activity without inhibitors, are shown.](molecules-24-00304-g006){#molecules-24-00304-f006}
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###### 

^1^H- and ^13^C-NMR data of ligurosides C and D in acetone-*d*~6~-D~2~O (9:1, *v*/*v*) (δ~H~: 600 MHz; δ~C~: 151 MHz).

  Position      Liguroside C         Liguroside D                        
  ------------- -------------------- -------------- -------------------- -------
  Monoterpene                                                            
  1             5.19 brd (18)        115.9          4.22 m               65.8
                5.18 brd (10.8)                     4.32 dd (6, 12)      
  2             5.92 dd (10.8, 18)   143.3          5.35 brt (6.6)       121.4
  3                                  80.7                                140.8
  4             2.32 d (6)           44.7           2.03 m               36.0
  5             5.63 dd (6, 15.6)    125.8          1.54 m, 1.64 m       29.5
  6             5.59 d (15.6)        138.5          4.21 m               88.8
  7                                  81.6                                145.4
  8             1.22 s               24.8           4.89 brs, 4.90 brs   113.7
  9             1.22 s               24.8           1.67 s               17.0
  10            1.31 s               23.1           1.65 s               16.3
  Glucosyl                                                               
  1′            4.78 d (7.8)         98.6           4.41 d (7.8)         101.9
  2′            3.38 brt (9)         75.5           3.40 brt (9)         75.5
  3′            3.78 t (9)           80.8           3.81 t (9)           80.8
  4′            4.85 t (9)           70.2           4.86 t (9)           70.2
  5′            3.52 m               75.2           3.52 m               75.5
  6′            3.54 m, 3.46 m       61.8           3.56 m, 3.49 m       61.9
  Rhamnosyl                                                              
  1′′           5.17 brs             102.1          5.17 brs             102.2
  2′′           3.90 m               71.5           3.90 m               71.5
  3′′           3.54 m               71.6           3.54 m               71.6
  4′′           3.29 t (9.6)         72.9           3.29 t (9.6)         73.0
  5′′           3.51 m               69.6           3.51 m               69.6
  6′′           1.02 d (6.6)         18.3           1.02 d (6.6)         18.3
  Coumaroyl                                                              
  1′′′                               126.3                               126.4
  2′′′          7.51 d (8.4)         131.0          7.51 d (8.4)         131.0
  3′′′          6.85 d (8.4)         116.6          6.86 d (8.4)         116.6
  4′′′                               160.8                               160.8
  5′′′          6.85 d (8.4)         116.6          6.86 d (8.4)         116.6
  6′′′          7.51 d (8.4)         131.0          7.51 d (8.4)         131.0
  7′′′          7.64 d (15.6)        146.7          7.63 d (15.6)        146.7
  8′′′          6.33 d (15.6)        114.5          6.33 d (15.6)        114.5
  9′′′                               167.5                               167.5
